These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 38420658)
1. Treatment of patients hospitalized for COVID-19 with remdesivir is associated with lower likelihood of 30-day readmission: a retrospective observational study. Mozaffari E; Chandak A; Gottlieb RL; Chima-Melton C; Kalil AC; Sarda V; Der-Torossian C; Oppelt T; Berry M; Amin AN J Comp Eff Res; 2024 Apr; 13(4):e230131. PubMed ID: 38420658 [No Abstract] [Full Text] [Related]
2. Remdesivir Effectiveness in Reducing the Risk of 30-Day Readmission in Vulnerable Patients Hospitalized for COVID-19: A Retrospective US Cohort Study Using Propensity Scores. Mozaffari E; Chandak A; Gottlieb RL; Kalil AC; Jiang H; Oppelt T; Berry M; Chima-Melton C; Amin AN Clin Infect Dis; 2024 Dec; 79(Supplement_4):S167-S177. PubMed ID: 39405450 [TBL] [Abstract][Full Text] [Related]
3. Association of Treatment with Remdesivir and 30-day Hospital Readmissions in Patients Hospitalized with COVID-19. Finn A; Jindal A; Andrea SB; Selvaraj V; Dapaah-Afriyie K Am J Med Sci; 2022 May; 363(5):403-410. PubMed ID: 35151637 [TBL] [Abstract][Full Text] [Related]
4. Real-world evaluation of early remdesivir in high-risk COVID-19 outpatients during Omicron including BQ.1/BQ.1.1/XBB.1.5. Molina KC; Webb BJ; Kennerley V; Beaty LE; Bennett TD; Carlson NE; Mayer DA; Peers JL; Russell S; Wynia MK; Aggarwal NR; Ginde AA BMC Infect Dis; 2024 Aug; 24(1):802. PubMed ID: 39118052 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19. Garibaldi BT; Wang K; Robinson ML; Zeger SL; Bandeen-Roche K; Wang MC; Alexander GC; Gupta A; Bollinger R; Xu Y JAMA Netw Open; 2021 Mar; 4(3):e213071. PubMed ID: 33760094 [TBL] [Abstract][Full Text] [Related]
6. Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19. Ohl ME; Miller DR; Lund BC; Kobayashi T; Richardson Miell K; Beck BF; Alexander B; Crothers K; Vaughan Sarrazin MS JAMA Netw Open; 2021 Jul; 4(7):e2114741. PubMed ID: 34264329 [TBL] [Abstract][Full Text] [Related]
7. The effect of early remdesivir administration in COVID-19 disease progression in hospitalised patients. Platzer M; Totschnig D; Karolyi M; Clodi-Seitz T; Wenisch C; Zoufaly A Wien Klin Wochenschr; 2024 Aug; 136(15-16):458-464. PubMed ID: 38884783 [TBL] [Abstract][Full Text] [Related]
8. Early administration of remdesivir to COVID-19 patients associates with higher recovery rate and lower need for ICU admission: A retrospective cohort study. Hussain Alsayed HA; Saheb Sharif-Askari F; Saheb Sharif-Askari N; Hussain AAS; Hamid Q; Halwani R PLoS One; 2021; 16(10):e0258643. PubMed ID: 34699552 [TBL] [Abstract][Full Text] [Related]
9. Remdesivir for the Treatment of Severe COVID-19: A Community Hospital's Experience. Lee S; Santarelli A; Caine K; Schritter S; Dietrich T; Ashurst J J Am Osteopath Assoc; 2020 Dec; 120(12):926-933. PubMed ID: 33136164 [TBL] [Abstract][Full Text] [Related]
10. Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients. Gottlieb RL; Vaca CE; Paredes R; Mera J; Webb BJ; Perez G; Oguchi G; Ryan P; Nielsen BU; Brown M; Hidalgo A; Sachdeva Y; Mittal S; Osiyemi O; Skarbinski J; Juneja K; Hyland RH; Osinusi A; Chen S; Camus G; Abdelghany M; Davies S; Behenna-Renton N; Duff F; Marty FM; Katz MJ; Ginde AA; Brown SM; Schiffer JT; Hill JA; N Engl J Med; 2022 Jan; 386(4):305-315. PubMed ID: 34937145 [TBL] [Abstract][Full Text] [Related]
11. Association of renal function with mortality among hospitalized patients treated with remdesivir for COVID-19. Gonzalez Suarez ML; Mara KC; Rivera CG; Chesdachai S; Draper E; Razonable RR PLoS One; 2024; 19(6):e0303896. PubMed ID: 38875257 [TBL] [Abstract][Full Text] [Related]
12. The effect of early versus late remdesivir treatment in hospitalized mild to moderate COVID-19 patients in the Omicron era: A retrospective study. Ryu BH; Lee JY; Lee SH Medicine (Baltimore); 2024 Jul; 103(29):e39035. PubMed ID: 39029053 [TBL] [Abstract][Full Text] [Related]
13. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial. Ader F; Bouscambert-Duchamp M; Hites M; Peiffer-Smadja N; Poissy J; Belhadi D; Diallo A; Lê MP; Peytavin G; Staub T; Greil R; Guedj J; Paiva JA; Costagliola D; Yazdanpanah Y; Burdet C; Mentré F; Lancet Infect Dis; 2022 Feb; 22(2):209-221. PubMed ID: 34534511 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of remdesivir-based therapy for moderate COVID-19: comparison of Omicron and other variant phases. Suzuki A; Fukumitsu K; Fukihara J; Katano T; Kako H; Maeda Y; Ishii M; Niimi A; Imaizumi K; Yamaguchi E J Chemother; 2024 Apr; 36(2):127-132. PubMed ID: 38044564 [TBL] [Abstract][Full Text] [Related]
15. Early remdesivir to prevent severe COVID-19 in recipients of solid organ transplant: a real-life study from Northern Italy. Colaneri M; Amarasinghe N; Rezzonico L; Pieri TC; Segalini E; Sambo M; Roda S; Meloni F; Gregorini M; Rampino T; Pelenghi S; Ricciardi A; Bruno R Int J Infect Dis; 2022 Aug; 121():157-160. PubMed ID: 35533831 [TBL] [Abstract][Full Text] [Related]
16. Remdesivir Reduced Mortality in Immunocompromised Patients Hospitalized for COVID-19 Across Variant Waves: Findings From Routine Clinical Practice. Mozaffari E; Chandak A; Gottlieb RL; Chima-Melton C; Read SH; Jiang H; Chiang M; Lee E; Gupta R; Berry M; Kalil AC Clin Infect Dis; 2023 Dec; 77(12):1626-1634. PubMed ID: 37556727 [TBL] [Abstract][Full Text] [Related]
17. Compassionate Use of Remdesivir in Children With Severe COVID-19. Goldman DL; Aldrich ML; Hagmann SHF; Bamford A; Camacho-Gonzalez A; Lapadula G; Lee P; Bonfanti P; Carter CC; Zhao Y; Telep L; Pikora C; Naik S; Marshall N; Katsarolis I; Das M; DeZure A; Desai P; Cao H; Chokkalingam AP; Osinusi A; Brainard DM; Méndez-Echevarría A Pediatrics; 2021 May; 147(5):. PubMed ID: 33883243 [TBL] [Abstract][Full Text] [Related]
18. Remdesivir for the Treatment of Covid-19 - Final Report. Beigel JH; Tomashek KM; Dodd LE; Mehta AK; Zingman BS; Kalil AC; Hohmann E; Chu HY; Luetkemeyer A; Kline S; Lopez de Castilla D; Finberg RW; Dierberg K; Tapson V; Hsieh L; Patterson TF; Paredes R; Sweeney DA; Short WR; Touloumi G; Lye DC; Ohmagari N; Oh MD; Ruiz-Palacios GM; Benfield T; Fätkenheuer G; Kortepeter MG; Atmar RL; Creech CB; Lundgren J; Babiker AG; Pett S; Neaton JD; Burgess TH; Bonnett T; Green M; Makowski M; Osinusi A; Nayak S; Lane HC; N Engl J Med; 2020 Nov; 383(19):1813-1826. PubMed ID: 32445440 [TBL] [Abstract][Full Text] [Related]
19. Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a propensity score matched analysis. Veronese N; Di Gennaro F; Frallonardo L; Ciriminna S; Papagni R; Carruba L; Agnello D; De Iaco G; De Gennaro N; Di Franco G; Naro L; Brindicci G; Rizzo A; Bavaro DF; Garlisi MC; Santoro CR; Signorile F; Balena F; Mansueto P; Milano E; Giannitrapani L; Fiordelisi D; Mariani MF; Procopio A; Lattanzio R; Licata A; Vernuccio L; Amodeo S; Guido G; Segala FV; Barbagallo M; Saracino A Sci Rep; 2024 Apr; 14(1):9303. PubMed ID: 38654033 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of remdesivir for the treatment of hospitalized COVID-19 persons: A network meta-analysis. Jiang Y; Chen D; Cai D; Yi Y; Jiang S J Med Virol; 2021 Feb; 93(2):1171-1174. PubMed ID: 32813283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]